Angiotensin II induces apoptosis of human endothelial cells: Protective effect of nitric oxide

Circulation Research

Volumn 81, Issue 6, 1997, Pages 970-976

  Dimmeler, Stefanie ^a   Rippmann, Volker ^b   Weiland, Ulrike ^b   Haendeler, Judith ^b   Zeiher, Andreas M ^b  

^a GOETHE UNIVERSITY   (Germany)

^b NONE

Author keywords

CGP42112; CPP32; EXP3174; PD123177; Protease

Indexed keywords

1 (4 AMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDROIMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; 2 BUTYL 4 CHLORO 1 [[2' (1H TETRAZOL 5 YL) 4 BIPHENYLYL]METHYL] 5 IMIDAZOLECARBOXYLIC ACID; ANGIOTENSIN; NICOTINOYLTYROSYL(N BENZYLOXYCARBONYLARGINYL)LYSYLHISTIDYLPROLYLISOLEUCINE; NITRIC OXIDE; PROTEINASE;

APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL TONE; CELL DEATH; CELL PROLIFERATION; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME SUBUNIT; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

EID: 0030817798     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.81.6.970     Document Type: Article

References (40)

1. Dzau VJ. Multiple pathways of angiotensin production in the blood vessel wall: evidence, possibilities and hypotheses. J Hypertens. 1989;7:933-936.
2. Itoh H, Mukoyama M, Pratt RE, Gibbons GH, Dzau VJ. Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. J Clin Invest. 1993;91:2268-2274.
3. Lyall F, Dornan ES, McQueen J, Boswell F, Kelly M. Angiotensin II increases proto-oncogene expression and phosphoinositide turnover in vascular smooth muscle cells via the angiotensin II AT1 receptor. J Hypertens. 1992;10:1463-1469.
4. Dzau VJ, Gibbons GH, Pratt RE. Molecular mechanisms of vascular renin-angiotensin system in myointimal hyperplasia. Hypertension. 1991;18(suppl II):II-100-II-105.
5. Stoll M, Steckelings UM, Paul M, Bottari SP, Metzger R, Unger T. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest. 1995;95:651-657.
6. White E. Life, death, and the pursuit of apoptosis. Genes Dev. 1996;10:1-15.
7. Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Wong WW, Yuan J. Human ICE/CED-3 protease nomenclature. Cell. 1996;87:171.
8. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, et al. Identification and inhibition of the ICE/CHD-3 protease necessary for mammalian apoptosis. Nature. 1995;376:37-43.
9. Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeug Z, Beidler DR, Poirier GG, Salvesen GS, Dixit VM. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell. 1995;81:801-809.
10. Kumar S. ICE-like proteases in apoptosis. Trends Biochem Sci. 1995;20:198-202.
11. Dimmeler S, Haendeler J, Rippmann V, Nehls M, Zeiher AM. Shear stress inhibits apoptosis of human endothelial cells. FEBS Lett. 1996;399:71-74.
12. Dimmeler S, Haendeler J, Nehls M, Zeiher AM. Suppression of apoptosis by nitric oxide via inhibition of ICE-like and CPP32-like proteases. J Exp Med. 1997;185:601-608.
13. Gibbons GH. Mechanisms of vascular remodeling in hypertension: role of autocrine-paracrine vasoactive factors. Curr Opin Nephrol Hypertens. 1995;4:189-196.
14. Pollman MJ, Yamada T, Horiuchi M, Gibbons GH. Vasoactive substances regulate vascular smooth muscle cell apoptosis: countervailing influences of nitric oxide and angiotensin II. Circ Res. 1996;79:748-756.
15. Mülsch A, Bauersachs J, Schäfer A, Stasch J-P, Kast R, Busse R. Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators. Br J Pharmacol. 1997;120:681-689.
16. Noris M, Morigi M, Donadelli R, Aiello S, Foppolo M, Todeschini M, Orisio S, Remuzzi G, Remuzzi A. Nitric oxide synthesis by cultured endothelial cells is modulated by flow conditions. Circ Res. 1995;76:536-543.
17. Rösl F. A simple and rapid method for detection of apoptosis in human cells. Nucleic Acids Res. 1992;20:5243.
18. Dimmeler S, Brinkmann S, Neugebauer E. Endotoxin-induced changes of endothelial cell viability and permeability: protective effect of a 21-aminosteroid. Eur J Pharmacal. 1995;287:257-261.
19. Bump NJ, Hackett M, Hugunin M, Seshagiri S, Brady K, Chen P, Ferenz C, Franklin S, Ghayur T, Li P, Licari P, Mankovich J, Shi L, Greenberg AH, Miller LK, Wong WW. Inhibition of ICE family proteases by baculovirus antiapoptotic protein p35. Science. 1995;269:1885-1888.
20. Tallant EA, Lu X, Weiss RB, Chappell MC, Ferrario CM. Bovine aortic endothelial cells contain an angiotensin-(1-7) receptor. Hypertension. 1997;29:388-393.
21. Dimmeler S, Haendeler J, Galle J, Zeiher AM. Oxidized low density lipoprotein induces apoptosis of human endothelial cells by activation of CPP32-like proteases: a mechanistic clue to the response to injury hypothesis. Circulation. 1997;95:1760-1763.
22. Yamada T, Horiuchi M, Dzau VJ. Angiotensin II type 2 receptor mediates programmed cell death. Proc Natl Acad Sci U S A. 1996;93:156-160.
23. Grady EF, Sechi LA, Griffin CA, Schambelan M, Kalinyak JE. Expression of AT2 receptors in the developing rat fetus. J Clin Invest. 1991;88:921-933.
24. Griendling KK, Alexander RW. The angiotensin (AT1) receptor. Semin Nephrol. 1993;13:558-566.
25. Liao D-F, Duff JL, Daum G, Pelech SL, Berk BC. Angiotensin II stimulates MAP kinase kinase kinase activity in vascular smooth muscle cells: role of Raf. Circ Res. 1996;79:1007-1014.
26. Oskarsson HJ, Heistad DD. Oxidative stress produced by angiotensin too: implications for hypertension and vascular disease. Circulation. 1997;95:557-559.
27. Jacobson MD. Reactive oxygen species and programmed cell death. Trends Biochem Sci. 1996;21:83-86.
28. Troy CM, Stefanis L, Prochiantz A, Greene LA, Shelanski ML. The contrasting roles of ICE family proteases and interlcukin-1β in apoptosis induced by trophic factor withdrawal and by copper/zinc superoxide dismutase down regulation. Proc Natl Acad Sci U S A. 1996;93:5635-5640.
29. De Gasparo M, Whitebread S, Mele M, Montani AS, Whitecombe PJ, Ramjoue HP, Kamber B. Biochemical characterization of two angiotensin II receptor subtypes in the rat. J Cadiovasc Pharmacol. 1990;16(suppl):S31-S35.
30. Nguyen T, Brunson D, Crespi CL, Penman BW, Wishnok JS, Tannenbaum SR. DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc Natl Acad Sci U S A. 1992;89:3030-3034.
31. Mannick JB, Asano K, Izumi K, Kieff E, Stamler JS. Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell. 1994;79:1137-1146.
32. Genaro AM, Hortelano S, Alvarez A, Martinez C, Bosca L. Splenic B lymphocyte programmed cell death is prevented by nitric oxide release through mechanisms involving sustained Bcl-2 levels. J Clin Invest. 1995;95:1884-1890.
33. Kim Y-M, de Vera ME, Watkins SC, Billiar TR. Nitric oxide protects cultured rat hepatocytes from tumor necrosis factor-alphainduced apoptosis by inducting heat shock protein 70 expression. J Biol Chem. 1997;272:1402-1411.
34. Lefer DJ, Scalia R, Campbell B, Nossuli T, Hayward R, Salamon M, Grayson J. Peroxynitrite inhibits leukocyte-endothelial cell interactions and protects against ischemia-reperfusion injury in rats. J Clin Invest. 1997;99:684-691.
35. Chobanian AV, Dzau VJ. Renin angiotensin system and atherosclerotic vascular disease. In: Fuster V, Ross R, Topol EJ, eds. Atherosclersosis and Coronary Artery Disease. Philadelphia, Pa: Lippincott-Raven; 1996;1:237-243.
36. Ross R. Cell biology of atherosclerosis. Annu Rev Physiol. 1995;57:791-804.
37. Caplan BA, Schwartz CJ. Increased endothelial cell turnover in areas of in vivo Evans blue uptake in the pig aorta. Athersclerosis. 1973;17:401-417.
38. Ross R. The pathogenesis of atherosclerosis: an update. N Engl J Med. 1986;314:488-500.
39. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Bard JM, Bara L, Ricard S, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 1992;359:641-644.
40. Alderman MH, Madhavan S, Ooi WL, Cohen H, Sealey JE, Laragh JH. Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. N Engl J Med. 1991;324:1098-1104.